By MEGGLE Excipients
To get in touch with MEGGLE Excipients, simply fill out the form below.
Subscribe to Supplier
MEGGLE displays attractive range of high-quality excipients and services at FCE Pharma Brazil
Wasserburg, Germany: – Pharmaceutical lactose specialist MEGGLE Excipients (MEGGLE) will emphasize its importance to the rapidly growing Latin American pharma manufacturing industry with a prominent presence at Brazil’s major Pharma Expo in São Paulo, FCE Pharma.
MEGGLE will again exhibit in partnership with its Brazilian exclusive distributor, Evonik Brasil, at Booth C027 in the São Paulo Expo Center. The stand displays will highlight MEGGLE’s latest generation lactose and co-processed excipients for pharma formulations and applications such as direct compression tabletting and dry powder inhalation (DPI).
Excipients for every application
The MEGGLE display will feature the InhaLac® range of sieved, milled and micronized DPI lactose powder excipients and the lactose based coprocessed excipients Cellactose®80, MicroceLac®100, StarLac®, RetaLac®, and CombiLac®, supported by the MEGGLE’s web-based Product Configurator that allows direct identification of ideal product by basic applications and characteristics.
On-stand videos will provide insights into MEGGLE’s rigorous production standards, advanced technology and pioneering research work.
Latin American growth
The MEGGLE team at the event will be led by Managing Director of MEGGLE Latin America, Fábio Luis Ikuno.
Mr. Ikuno commented: “We are looking forward very much to returning to this stellar Latin American pharma event, which provides us with a great platform for networking, following up previous suggestions and initiating new projects.”
Once again, it enables us to keep up to date with latest tendencies in these fast-growing Latin American markets, hear about new developments and grow our businesses in lactose-based excipients and value added services,” he added.
About MEGGLE Wasserburg
Bavarian-based MEGGLE is one of the world’s experts in co-processing and powder technology. From its roots as a dairy operation in the late 1880’s, MEGGLE has become one of the world’s leading manufacturers of pharmaceutical lactose, supplying the pharma market segment with a broad-based and unique lactose product portfolio.
MEGGLE Business Unit Excipients has harnessed outstanding product quality and intelligent innovation to become a global leader in the manufacture of lactose-based excipients, focusing on products for direct tableting and dry powder inhalation.
A multidisciplinary team of committed and highly qualified people allows MEGGLE clients to benefit from pioneering experience and innovative drive in industrial milk and whey processing. The company constantly strives to develop high-tech, functional products for solid dosage forms and DPI applications, where they can deliver maximum performance.
The company has introduced several revolutionary products, notably Tablettose®, the world’s first agglomerated lactose grade for direct tableting, Cellactose® 80, a pioneering co-processed excipient based on cellulose-lactose for outstanding compression and flow properties and RetaLac®, the first direct compression co-processed excipient using a hypromellose-lactose base for sustained release formulations.
To learn more, visit: www.meggle-excipients.com
About FCE Pharma 2023
The FCE Pharma Expo is an annual event that has become a principal marketing, communications and sales platform for the South and Central American pharmaceutical industry. FCE Pharma is unique in Latin America in bringing the biggest products and services suppliers from across the pharmaceutical industry production chain together under one roof and is a major driver of the pharma-based economy in the region.
Featuring four conference tracks, and a co-located trade exhibition, the 27th FCE Pharma Expo (FCE Brasil 2023) will again be a three-day event opening June 13 at the São Paulo Expo center in, Brazil.
The previous FCE Pharma in 2022 confirmed the event’s continued growth, attracting more than 15,000 visitors and a record 600+ exhibitors, representing pharma manufacture, supply and distribution of products and services including packaging, labeling, machines and equipment, quality and contamination control, transport and logistics, outsourcing and consultancy, laboratory and analytical equipment, process equipment, valves, sprays, industrial automation, technology and printing services.
The event is organized by Nürnberg Messe Brazil with more information at https://home.fcepharma.com.br/